Prihlásiť sa Zaregistrujte sa zadarmo

Hotovosť na akciu spoločnosti Beam Therapeutics

Aká je hodnota metriky Hotovosť na akciu spoločnosti Beam Therapeutics?

Hodnota metriky Hotovosť na akciu spoločnosti Beam Therapeutics Inc. je 9.14

Aká je definícia metriky Hotovosť na akciu?

Hotovosť na akciu (Cash per share) je pomer ihneď dostupných peňazí prístupných na výdaj a vydaných akcií spoločnosti.

Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.

When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.

Hotovosť na akciu spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Beam Therapeutics

Čomu sa venuje spoločnosť Beam Therapeutics?

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Firmy s metrikou hotovosť na akciu podobnou spoločnosti Beam Therapeutics



  • Hodnota metriky Hotovosť na akciu spoločnosti Edenred SA je 9.11
  • Hodnota metriky Hotovosť na akciu spoločnosti Sopra Steria SA je 9.12
  • Hodnota metriky Hotovosť na akciu spoločnosti BILL Inc je 9.12
  • Hodnota metriky Hotovosť na akciu spoločnosti Bhansali Engineering Polymers je 9.13
  • Hodnota metriky Hotovosť na akciu spoločnosti Bajaj Electricals je 9.14
  • Hodnota metriky Hotovosť na akciu spoločnosti Zhongliang je 9.14
  • Hodnota metriky Hotovosť na akciu spoločnosti Beam Therapeutics je 9.14
  • Hodnota metriky Hotovosť na akciu spoločnosti Prime Focus je 9.14
  • Hodnota metriky Hotovosť na akciu spoločnosti Hang Seng Bank je 9.14
  • Hodnota metriky Hotovosť na akciu spoločnosti Kubota je 9.15
  • Hodnota metriky Hotovosť na akciu spoločnosti The South India Paper Mills je 9.15
  • Hodnota metriky Hotovosť na akciu spoločnosti ITOCHU je 9.16
  • Hodnota metriky Hotovosť na akciu spoločnosti IQVIA Inc je 9.17